Search

everythinglearnresearchcommunity

for

Search:↓

Intravenous calcium therapy is a safe and effective treatment for a rare type of rickets.

Topical calcitriol appears safe and may reduce hair loss during chemotherapy.

Alpha-tocopherol does not prevent hair loss from doxorubicin.

Targeted therapy with Ustekinumab significantly improved a skin condition called ILVEN, which is caused by mutations in the CARD14 gene.

Protein Kinase C shows promise for cancer treatment, but more research is needed to develop effective inhibitors.

A new engineered treatment shows promise in curing heart fibrosis.

Tamsulosin works faster, but both drugs have similar effects after 6 months.

A new combination of tadalafil and finasteride improves drug performance and stability.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

The lotion CG428 did not show effectiveness in treating permanent hair loss in breast cancer survivors.

FTY720 helps transplanted fat survive better by reducing immune rejection and improving blood vessel growth.

Six key genes can predict bladder cancer outcomes and may serve as prognostic biomarkers.

Dutasteride effectively treats enlarged prostate with manageable side effects.

Local testosterone treatment improved sexual desire in a female with fragile X syndrome.

Ixekizumab has known and some unexpected side effects.

A combination of nanomilled oral testosterone and dutasteride normalized testosterone levels in men with low testosterone and is safe for short-term use.

Botulinum toxin injections improved hair thinning in a woman with hair loss.

Certain drugs increase calcium levels in cancer cells by triggering internal calcium release.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

Tofacitinib may help treat severe hair loss, but more research is needed.

Dutasteride injections can help treat hair loss in men and women.

Tofacitinib helps hair regrow in some kids with severe alopecia areata, but more research is needed on long-term effects.

Clofazimine effectively treated ashy dermatosis in a patient.

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.

Tofacitinib effectively promotes hair regrowth in alopecia areata with minimal side effects.

TPA is about 50 times more effective at promoting tumors than MZ.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.